MATERIALS AND METHODS

Mild to Moderate Kidney Disease Study (MMKD Study)
Exclusion criteria were defined as: serum creatinine >6 mg/dL (531 µmol/L), diabetes mellitus of any type, malignancy, liver, thyroid, or infectious diseases, nephrotic syndrome (defined as daily proteinuria >3.5g/1.73m 2 ), organ transplantation, immunosuppressive treatment, allergy to ionic contrast media, treatment with fish oil or erythropoietin and pregnancy.
All patients were recruited by a single investigator who visited all participating centers to avoid interobserver differences. Information on age, gender, smoking habits, comorbidities and antihypertensive treatment at baseline was recorded by patient interview and confirmed by checking patient records. A clinical examination completed the procedure. Hypertension was defined as BP >140/90 mmHg and/or the use of antihypertensive medication.
Patients received regular reviews in the outpatient ward. Endpoints were assessed by medical record abstraction and reported to the coordinating center.
Unless they had reached the primary endpoint, patients were followed until the end of the whole follow-up time period of 7 years. A total of 177 (78%) patients from the baseline cohort of 227 patients could be followed prospectively. Due to inappropriate or missing laboratory samples (n=11) or missing of follow-up data (n=50), the values of RTL were available in 166 patients.
A total of 50 patients were lost to follow-up. They moved away or were not referred by their physicians for follow-up visits in the renal units. Significantly better renal function at baseline was observed when compared to patients who were not lost to follow-up (i.e., a higher mean GFR [91±44 versus 64±39 ml/min per 1.73 m Samples were normalized in 96-well microtiter plates. Samples were ascertained in a singleplex, quadruplicate approach to measure the T/S-ratios. These T/S-ratios are proportional to individual relative telomere length (RTL). RTL was measured with some modifications as described below by using a quantitative real-time polymerase chain reaction (qPCR) assay, which was first described by Cawthon The thermal cycling began with the initial polymerase activation step (10 min at 95°C) and was followed by 40 cycles of 95°C for 15 s, 60°C for 1 min. A melting curve analysis to verify the specificity and identity of the products was performed. sample were used. Relative T/S-ratios reflect relative telomere length differences.
To test the reproducibility of RTL measurement, the inter-assay CV of T/S-ratios was calculated according to the following formula:
About 5% of all samples in both studies were analyzed in duplicate. Duplicate samples were never positioned on the same plate or at the same plate position. They were taken from different original DNA plates. Inter-assay CV of T/S-ratios of duplicates was 7.8% in CRISIS.
As second RTL measurement quality control, we analyzed the relative telomere length of a commercially available DNA, which was positioned on each 384-well plate (a total of 24 plates). Inter-assay CV of T/S-ratios of this 24 times analyzed sample was 3.4%. In case of MMKD, inter-assay CV of T/S-ratios of duplicates was 12% and of quality control 6.9% (6 plates).
T/S-ratio values of CRISIS and MMKD are not directly comparable as different DNA extraction methods were used but can be interpreted in the same manner within both studies.
Several methods of TL measurement have been published so far. Compared to the Southern blot method, the quantitative polymerase chain reaction (qPCR) requires far less amount of DNA and is a high-throughput method. It is therefore widely used for large epidemiological studies. The qPCR assay provides the ratio of the telomere (T) and the housekeeping gene 36B4 (S) that should be proportional to the RTL of an individual. The comparison between these two methods has been published previously 5 .
Statistical Analysis Line plot
Marginal mean values and 95% CI of relative telomere length (RTL) (age-and sex-adjusted)
were derived by general linear regression models. In a next step, differences in marginal mean values were compared over chronic kidney disease (CKD) stages defined by the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines.
Proportional hazards assumption
All calculated Cox regression analyses in the MMKD Study did not depart from the proportional hazards assumption. In the CRISIS Study, in the total group and in non-smokers and non-diabetics, the fully adjusted Cox regression Model 3 did depart from the proportional hazards (PH) assumption. As the deviation from the PH assumption was mainly due to GFR, we included a covariate in the respective models that accounts for the time-dependency of GFR. Thus, the HRs shown for relative telomere length are adjusted for this time effect (see Table 2 ).
Sensitivity analysis
To exclude that the association of RTL with progression of CKD in active smokers and patients with diabetes is confounded by angiotensin-converting-enzyme inhibitors (ACEi) 
Investigation of the yearly GFR change in the CRISIS Study
The first and the last eGFR calculation of the CRISIS study were used to calculate an average yearly GFR decline. A non-linear P-spline was used to check for linearity of yearly GFR change in a general linear regression analysis on RTL in active smokers. Yearly GFR change was inverse-normal transformed due to its skewed distribution. This analysis was adjusted for age, sex, proteinuria and GFR at baseline. As can be seen from Supplementary Figure 1 linearity was not present and we therefore performed the analysis using tertiles.
Supplementary Figure 1: Non-linear P-spline to check for linearity of yearly GFR change in a general linear regression analysis on RTL in active smokers (for explanation see text). Vertical lines represent the borders of the tertiles.
